Global Rare Disease Drug Market Study 2016-2026, by Segment (>1, 0.65 1, … …), by Market (Hospital Pharmacies, Speciality Pharmacies, … …), by Company (Novartis AG, Bristol-Myers Squibb Company, … …)
SKU ID :99ST-14631697 | Published Date: 29-Oct-2019 | No. of pages: 62Description
Summary
The global Rare Disease Drug market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
>1
0.65 1
<0.1
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Hospital Pharmacies
Speciality Pharmacies
Retail pharmacies
Others
Novartis AG
Bristol-Myers Squibb Company
Celgene Corporation
F. Hoffmann-La Roche Ltd.
Pfizer, Inc.
Sanofi S.A.
Alexion Pharmaceuticals, Inc.
Eli Lilly and Company
Novo Nordisk A/S
AstraZeneca
Eisai Co., Ltd.
Daiichi Sankyo Company Limited
Bayer AG
GlaxoSmithKline
Merck & Co., Inc.
Johnson & Johnson
Biogen, Inc.
Shire
Amgen, Inc.
Deciphera
Atara Biotherapeutics
ProQR
North America
Europe
Asia-Pacific
South America
Middle East & Africa
The global Rare Disease Drug market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
>1
0.65 1
<0.1
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Hospital Pharmacies
Speciality Pharmacies
Retail pharmacies
Others
Company Coverage (Sales data, Main Products & Services etc.):
Novartis AG
Bristol-Myers Squibb Company
Celgene Corporation
F. Hoffmann-La Roche Ltd.
Pfizer, Inc.
Sanofi S.A.
Alexion Pharmaceuticals, Inc.
Eli Lilly and Company
Novo Nordisk A/S
AstraZeneca
Eisai Co., Ltd.
Daiichi Sankyo Company Limited
Bayer AG
GlaxoSmithKline
Merck & Co., Inc.
Johnson & Johnson
Biogen, Inc.
Shire
Amgen, Inc.
Deciphera
Atara Biotherapeutics
ProQR
Major Region
MarketNorth America
Europe
Asia-Pacific
South America
Middle East & Africa
TOC
Tables & Figures
Companies
- PRICE
-
$1800$3600Buy Now